PTX 7.50% 3.7¢ prescient therapeutics limited

Ann: Third complete response in PTX-200 AML Trial, page-206

  1. 909 Posts.
    lightbulb Created with Sketch. 85
    Surprised at the price action considering the fact that the primary endpoint is unlikely to be met. Add the history of prior troubles with the drug. Watching this space with interest nonetheless.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.